Interferon alfa-2a in the treatment of cutaneous T cell lymphoma (Q69735852)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783939%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

title

Interferon alfa-2a in the treatment of cutaneous T cell lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783939%20AND%20SRC:MED&resulttype=core&format=json

cutaneous T cell lymphoma

5 October 2019

main subject

1 reference

E A Olsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783939%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

S T Rosen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783939%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

R T Vollmer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783939%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

D Variakojis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783939%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

H H Roenigk

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783939%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

N Diab

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783939%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

J Zeffren

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783939%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

language of work or name

English

0 references

publication date

1 March 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783939%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

5 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783939%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783939%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783939%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

page(s)

395-407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783939%20AND%20SRC:MED&resulttype=core&format=json

Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants

5 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Mycosis fungoides: the pathology of extracutaneous involvement.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Clinical course of retrovirus-associated adult T-cell lymphoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Prognostic signs and the management of the mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Cutaneous T-cell lymphoma: clinicopathological relationships, therapy and survival in ninety-two patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Photochemotherapy in mycosis fungoides. A study of 73 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Photochemotherapy for cutaneous T cell lymphoma. A follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Photochemotherapy in cutaneous T cell lymphoma and parapsoriasis en plaques. Long-term follow-up in forty-three patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Cutaneous T-cell lymphoma: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Interferons in the treatment of human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Alpha interferon for induction of remission in hairy-cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Central nervous system involvement in hairy cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Intermittent Melphalan Therapy in Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Side Effects of Long-Term Treatment with Human Leukocyte Interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

PRIMARY HYPOTHYROIDISM ASSOCIATED WITH INTERFERON THERAPY OF BREAST CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Ulcerative colitis after bone-marrow transplantation for acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Immunomodulatory and antiproliferative effect of recombinant alpha, beta, and gamma interferons on cultured human malignant squamous cell lines, SCL-1 and SW-1271

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Effects of alpha and beta interferons on cultured human keratinocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Clinical studies of recombinant interferon alfa-2a (Roferon-A) in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Inflammation of actinic keratosis secondary to systemic 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Leukocyte interferon in patients with juvenile laryngeal papillomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

UCLA conference. Interferon: immunobiology and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Effects of recombinant leukocyte interferon (rIFN-alpha A) on tumour growth and immune responses in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Brief communication: Cure of murine leukemia with drug and interferon treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

Combined interferon--antimetabolite therapy of murine L1210 leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970049-9

7 January 2021

10.1016/S0190-9622(89)70049-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2783939%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference